You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NBIX Award Disclosure
Roberts Eiry · SEC Form 4 · Filed Nov 5, 2026
Award
Calculated transaction value
$0
Roberts Eiry Chief Medical Officer
NBIX
Transaction date
Nov 4, 2026
Public filing date
Nov 5, 2026
Filing lag
Filed 1 day later
NBIX daily price context
Close on/before transaction
$166.05
Nov 4, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Unit on Common Stock
- Quantity / price
- 1,506 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001727606-26-000007
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Neurocrine Biosciences Inc NBIX | Award | Nov 4, 2026 | $0 |
| Neurocrine Biosciences Inc NBIX Current | Award | Nov 4, 2026 | $0 |